Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-09

Clinical Trial Update: Renal Allograft Tolerance Through Mixed Chimerism - SMC/MGH [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating renal allograft tolerance through mixed chimerism at Massachusetts General Hospital and SMC; the study is currently active but…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Renal Failure | Phase 1 | Status: ACTIVE_NOT_RECRUITING